Displaying 2101 - 2120 of 4735
FTC Releases Staff Study Examining Commission Merger Remedies between 2006 and 2012
United States (For the Federal Trade Commission) v. Fayez Sarofim
Investment firm founder Fayez Sarofim agreed to pay $720,000 in civil penalties to resolve allegations that he violated the Hart-Scott-Rodino Act by failing to report stock purchases from several issuers between 2001 and 2012. The HSR Act exempts acquisitions of up to ten percent of voting securities if they are made solely for investment purposes, but this exemption is not available to individuals who serve on the board of directors of the issuer at the time the shares are acquired. The FTC alleged that because Sarofim was serving as a board member at each company for which he acquired voting shares, he was ineligible for an investment-only exemption from filing and his failure to report a series of transactions to U.S. antitrust authorities violated the Act. From 2001 to 2012, Sarofim acquired voting shares of energy infrastructure company Kinder Morgan, Inc., crossing three different filing thresholds without making the filings required under the HSR Act. In 2007, he acquired voting shares in insurance holding company Kemper Corporation and did not file as required under the Act. According to the complaint, he was already serving as a board member at Kinder Morgan and at Kemper’s predecessor company, Unitrin Inc., before he made the respective stock purchases.
Statement of Acting FTC Chairman Ohlhausen on Appointment by President Trump
Antitrust Policy for a New Administration
Endo Pharmaceuticals Inc. Agrees to Abandon Anticompetitive Pay-for-Delay Agreements to Settle FTC Charges; FTC Refiles Suits Against Generic Defendants
The FTC's Merger Remedies 2006-2012: A Report of the Bureaus of Competition and Economics
17010005 Informal Interpretation
FTC Announces Annual Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates
Puerto Rico Ophthalmologist Group Settles FTC Charges that Members Agreed to an Illegal Boycott of Health Plan
Concurring Statement of Commissioner Maureen K. Ohlhausen In the Matter of Mallinckrodt ARD Inc.
Mallinckrodt Will Pay $100 Million to Settle FTC, State Charges It Illegally Maintained its Monopoly of Specialty Drug Used to Treat Infants
FTC Charges Qualcomm With Monopolizing Key Semiconductor Device Used in Cell Phones
In Two Separate Actions, FTC Charges Investors with Violations of U.S. Premerger Notification Requirements
Displaying 2101 - 2120 of 4735